» Articles » PMID: 15583272

Amoebal Coculture of "Mycobacterium Massiliense" Sp. Nov. from the Sputum of a Patient with Hemoptoic Pneumonia

Overview
Specialty Microbiology
Date 2004 Dec 8
PMID 15583272
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

A nonphotochromogenic, rapidly growing Mycobacterium strain was isolated in pure culture from the sputum and the bronchoalveolar fluid of a patient with hemoptoic pneumonia by using axenic media and an amoebal coculture system. Both isolates grew in less than 7 days at 24 to 37 degrees C with an optimal growth temperature of 30 degrees C. The isolates exhibited biochemical and antimicrobial susceptibility profiles overlapping those of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium immunogenum, indicating that they belonged to M. chelonae-M. abscessus group. They differed from M. abscessus in beta-galactosidase, beta-N-acetyl-beta-glucosaminidase, and beta-glucuronidase activities and by the lack of nitrate reductase and indole production activities, as well as in their in vitro susceptibilities to minocycline and doxycycline. These isolates and M. abscessus differed from M. chelonae and M. immunogenum by exhibiting gelatinase and tryptophane desaminase activities. Their 16S rRNA genes had complete sequence identity with that of M. abscessus and >99.6% similarity with those of M. chelonae and M. immunogenum. Further molecular investigations showed that partial hsp65 and sodA gene sequences differed from that of M. abscessus by five and three positions over 441 bp, respectively. Partial rpoB and recA gene sequence analyses showed 96 and 98% similarities with M. abscessus, respectively. Similarly, 16S-23S rRNA internal transcribed spacer sequence of the isolates differed from that of M. abscessus by a A-->G substitution at position 60 and a C insertion at position 102. Phenotypic and genotypic features of these two isolates indicated that they were representative of a new mycobacterial species within the M. chelonae-M. abscessus group. Phylogenetic analysis suggested that these isolates were perhaps recently derived from M. abscessus. We propose the name of "Mycobacterium massiliense" for this new species. The type strain has been deposited in the Collection Institut Pasteur as CIP 108297(T) and in Culture Collection of the University of Goteborg, Goteborg, Sweden, as CCUG 48898(T).

Citing Articles

Polymicrobial infection in cystic fibrosis and future perspectives for improving Mycobacterium abscessus drug discovery.

Baker E, Allcott G, Cox J NPJ Antimicrob Resist. 2025; 2(1):38.

PMID: 39843836 PMC: 11721438. DOI: 10.1038/s44259-024-00060-5.


Cyclophostin and Cyclipostins analogues counteract macrolide-induced resistance mediated by erm(41) in Mycobacterium abscessus.

Sarrazin M, Poncin I, Fourquet P, Audebert S, Camoin L, Denis Y J Biomed Sci. 2024; 31(1):103.

PMID: 39623375 PMC: 11613490. DOI: 10.1186/s12929-024-01091-w.


Unlocking the Mycobacteroides abscessus pan-genome using computational tools: insights into evolutionary dynamics and lifestyle.

Karmakar M, Sur S Antonie Van Leeuwenhoek. 2024; 118(1):30.

PMID: 39579164 DOI: 10.1007/s10482-024-02042-z.


Global prevalence of strains with recombinant genes (Rec-Mas) horizontally transferred from : two major types, dominant circulating clone 7 and MLST ST46 sequence type.

Kim D, Seo H, Jung S, Kim B Microbiol Spectr. 2024; :e0193524.

PMID: 39431893 PMC: 11619318. DOI: 10.1128/spectrum.01935-24.


Repurposing miconazole and tamoxifen for the treatment of Mycobacterium abscessus complex infections through in silico chemogenomics approach.

Dos Anjos L, Costa V, Neves B, Junqueira-Kipnis A, Kipnis A World J Microbiol Biotechnol. 2023; 39(10):273.

PMID: 37553519 DOI: 10.1007/s11274-023-03718-w.


References
1.
Swenson J, Wallace Jr R, Silcox V, Thornsberry C . Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 1985; 28(6):807-11. PMC: 180333. DOI: 10.1128/AAC.28.6.807. View

2.
Conville P, Witebsky F . Variables affecting results of sodium chloride tolerance test for identification of rapidly growing mycobacteria. J Clin Microbiol. 1998; 36(6):1555-9. PMC: 104876. DOI: 10.1128/JCM.36.6.1555-1559.1998. View

3.
Selvarangan R, Wu W, Nguyen T, Carlson L, Wallis C, Stiglich S . Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov. J Clin Microbiol. 2004; 42(1):52-9. PMC: 321678. DOI: 10.1128/JCM.42.1.52-59.2004. View

4.
WOLINSKY E . Mycobacterial diseases other than tuberculosis. Clin Infect Dis. 1992; 15(1):1-10. DOI: 10.1093/clinids/15.1.1. View

5.
Greub G, La Scola B, Raoult D . Amoebae-resisting bacteria isolated from human nasal swabs by amoebal coculture. Emerg Infect Dis. 2004; 10(3):470-7. DOI: 10.3201/eid1003.020792. View